Find the products and resources you are looking for!
Get in touch!
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Cookie Settings
We use cookies in order to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement.
Friday, July 5, 2019
09:00 a.m.–06:00 p.m.
Aula Magna “Giovanni Agnelli”– Politecnico di Torino
Corso Duca degli Abruzzi, 24
Turin
09:00 a.m. | Welcome addresses Carlo Levi, Francesco Profumo, Ruggero De Maria, Giuseppe Basso |
Morning session New mechanistic basis for cancer immunotherapy Chairs: Andrea Pagnani (PoliTo, IIGM), Francesca Di Rosa (Institute of Molecular Biology and Pathology, CNR, Rome) | |
09:30 a.m. | Innate immunity, inflammation, and cancer: double-edged swords Alberto Mantovani, Humanitas, Rozzano |
10:00 a.m. | NK cell-mediated cancer immunochemotherapy Angela Santoni, Sapienza Università di Roma, Rome |
10:30 a.m. | NK cells in the therapy of acute, high-risk leukemia: KIR/HLA-I mismatch and more Lorenzo Moretta, OPBG, Rome |
11:00 a.m. | Coffee break |
11:30 a.m. | Epigenetic immune remodelling to improve the efficacy of checkpoints-based cancer therapy Michele Maio, CIO, Siena |
12:00 p.m. | Epigenetic and transcriptional control during CD8+ T cell fate commitment Luigia Pace, IIGM, Turin |
12:30 p.m. | Antibody evolution in the presence or absence of clonal selection Antonio Lanzavecchia, IRB, Bellinzona01:00 p.m. |
01:00 p.m. | Lunch |
Afternoon session I Tumor immune surveillance and microenvironment Chairs: Franco Novelli (UniTo), Enzo Medico (UniTo, IRCCS Candiolo) | |
02:15 p.m. | Tumor immunosurveillance and immunotherapy by lipid-specific T cells Paolo Dellabona, HSR, Milan |
02:45 p.m. | Comprehensive analysis of tumor microenvironment from limited patient samples Cesar Evaristo, Miltenyi Biotec, R&D, Germany |
03:15 p.m. | Cancer secretome unveils the secrets of immunosuppression in tumor microenvironment Vincenzo Barnaba, Sapienza Università di Roma, Rome |
03:45 p.m. | Coffee break |
Afternoon session II Programming immune cells for immunotherapy Chairs: Franca Fagioli (UniTo), Dario Sangiolo (UniTO, Candiolo IRCCS) | |
04:05 p.m. | T lymphocyte diversity: matching specificity and function Federica Sallusto, IRB, Bellinzona |
04:35 p.m. | CAR T cell therapy: from bench to bedside and beyond Concetta Quintarelli, OPBG, Rome |
05:05 p.m. | Microbiota and cancer treatment Maria Rescigno, Humanitas, Rozzano |
05:35 p.m. | Closing remarks |
Please register online here or call 051 6460420 by June 28, 2019.
Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.